Lee ahora

WMS 2020

Descubre los aspectos más destacados de la conferencia

Early vs late use of high-efficacy therapies in multiple sclerosis

neurodiem-image

Real-world registry data indicate that early use of high-efficacy therapies may reduce disability in patients with multiple sclerosis (MS).

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.